Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × loncastuximab tesirine × Clear all

NCT05190705 2025-05-23

Loncastuximab Tesirine in WM

Phase 2 Recruiting

Waldenstrom Macroglobulinemia